Related Experiment Videos
Rhinocerebral Mucormycosis: consideration of prognostic factors and treatment modality
Sang-Hee Jung1, Sung Won Kim, Chan Soon Park
1Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Objectives:
Rhinocerebral mucormycosis is rare, rapidly progressive, potentially life-threatening disease, and it usually occurs in immunocompromised patients. We present our clinical experience with 12 cases and we attempt to identify the prognostic features and proper treatment protocols.
Patients And Methods:
All the cases of mucormycosis were proven by histology or culture. The prognosis was analyzed according to the predisposing factors, including underlying disease, extent of disease and surgical intervention.
Result:
The overall mortality rate in our series was 33.3%. 7 of the 10 operated patients recovered, while 1 of the 2 non-operated patients expired. The associated conditions included diabetes mellitus (n=9) and hematological disease (n=3). A poor prognosis was primarily related with uncontrolled underlying disease. Other associated prognostic factors were the extent of disease including orbital or intracranial extension. Surgical debridement is essential for a good prognosis, but timely intervention and complete aggressive debridement are not always needed in all patients. The patient who had slowly progressive disease also survived after conventional medical management and limited surgical debridement, including orbital preservation.
Conclusion:
Control of the underlying predisposing illness along with prompt parenteral administration of amphotericin B and aggressive surgical debridement remain the essential treatments even today. Contrary to this, as described in this study, for the patients with slowly progressive disease, the aggressive surgical debridement is spared, and a successful result may be obtained with the conventional management, including medical treatment and timely limited surgical intervention.
Insights
Rhinocerebral mucormycosis management requires controlling underlying conditions and prompt treatment. Aggressive surgery is vital for severe cases, but less invasive approaches may suffice for slowly progressing disease.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Surgical Oncology
Background:
- Rhinocerebral mucormycosis is a rare, aggressive fungal infection.
- It predominantly affects immunocompromised individuals.
- Early diagnosis and intervention are critical for patient survival.
Purpose of the Study:
- To review clinical experience with 12 cases of rhinocerebral mucormycosis.
- To identify prognostic factors influencing patient outcomes.
- To evaluate optimal treatment protocols for this condition.
Main Methods:
- Histological or culture confirmation of mucormycosis in all cases.
- Prognostic analysis based on predisposing factors, disease extent, and surgical intervention.
- Retrospective review of patient data and treatment outcomes.
Main Results:
- Overall mortality rate was 33.3%.
- Surgical intervention improved survival rates (7/10 recovered).
- Uncontrolled underlying diseases (diabetes, hematological disorders) and extensive disease (orbital/intracranial) correlated with poor prognosis.
Conclusions:
- Controlling underlying illnesses and prompt amphotericin B administration are key.
- Aggressive surgical debridement is essential for most cases.
- Less aggressive surgical management may be successful in slowly progressive disease.
Related Concept Videos
01:27Cryptococcal Meningitis
01:29Fungal Group Zygomycota
01:26Rocky Mountain Spotted Fever